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Abstract 
5-1odotubercidin (Itu) and proglycosyn (Pro) have similar glycogenic properties. To compare their mechanisms of action, we tested 
them in hepatocytes from fasted rats. We show that both compounds are similar in that they stimulated glycogen synthesis, increased the 
concentration of synthase a, decreased that of phospho~'lase u and Io~ered the concentration of F-2,6-P~ in the presence of glucose, 
lactate-pyruvate and amino acids. However. when amino acids were absent. Pro was the better stimulator f glycogenesis than Itu and in 
combination they elevated glycogen and synthase a concentrations ~ynergi~tieall~. Further they differ in that (I) Itu enhanced the levels 
of cyclic AMP whereas Pro did not; (2) Pro depressed glucose production from gluconeogenic substrates, whereas Itu stimulated this 
process; (3) the inhibition of F-2•6-P_, formation and glycolysis by Pro became much weaker than that by ltu when glucose concentrations 
were raised from I0 to 20 mM. Inhibition of glycolysis but not that of glycogen synthesis was partly due to a phosphorylated metabolite 
of ltu. The present study indicates that despite their simi!ar glycogenic eflects, Itu and Pro do not share a common mechanism of action. 
Further, the inhibition of glycolysis and :-2,6-P, formation by hu cannot be explained if it acts solely as a general inhibitor of protein 
kinases. 
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1. Introduction 
In hepatocytes from fasted rats, the adenosine kinase 
inhibitor 5-iodotubercidin strongly stimulates glycogen 
synthesis from various substrates [I]. The mechanism of 
this stimulation differs from the one of amino acids in that 
the combined action of Itu and amino acids on glycogen 
depostion is more than additive [I] and further, in contrast 
to certain amino acids [2,3], Itu increases neither the cell 
volume nor the concentrations of aspartate and glutamate 
[I]. The promotion of glycogenesis by Itu is accompanied 
by an increase in the concentration of glycogen synthase a
and a decrease in that of active phosphorylase [1]. Very 
similar effects have been described for the phenacylimida- 
zolium compound proglycosyn [4-6]. In hepatocytes from 
normal and streptozotocin diabetic rats, Pro and glutamine 
s.,nergistically stimulate the synthesis of glycogen [6]. Pro 
Abbreviations: Itu, 5-iodotubercidin; Pro. proglycosyn: F-2.6-P_,. fruc- 
tose-2.6-bisphosphate. 
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activates hepatic glycogen synthase and inactivates glyco- 
gen phosphorylase without causing cell swelling [5]. The 
apparently identical glycogenic properties of two chemi- 
cally different compounds might suggest hat Itu and Pro 
share a common mechanism of action. The only difference 
in metabolic effects between ltu and Pro observed so far is 
that Itu enhances the levels of cyclic AMP [I] whereas Pro 
has no significant effect [5]. As Itu has been shown to be a 
general inhibitor of protein kinases [7], its glycogenic 
action could possibly result from an inhibition of phospho- 
rylase kinase and various synthase kinases. Although Pro. 
or its demethylated, glucuronidated derivative [8]. has been 
proposed to stimulate glycogen synthesis by an activation 
of protein phosphatase(s), its inhibitory effects on protein 
kinases were not investigated and therefore cannot be 
excluded [5]. In addition, the glycogenic action of both 
compounds cannot be explained by an effect on cyclic 
AMP or calcium [1,5,7]. Pro has been reported to have 
several glucagon-like effects on hepatic metabolism in that 
it decreases the concentration of F-2,6-P:, inhibits glycoly- 
sis. inhibits fatty acid synthesis and stimulates fatty acid 
oxidation [5]. Furthermore. Pro inhibits net glucose pro- 
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duction from gluconeogenic precursors [4,6] by diverting 
the gluconeogenic flux from glucose to glycogen [6]. How- 
ever. the observed effects of Pro on F-2,6-~ concentra- 
tions and on glycolysis cannot be explained by the sugges- 
tion that it activates protein phosphatase(s). Until now. Pro 
and Itu have been investigated separately by differcnt 
laboratories and under different incubation conditions. To 
get a direct comparison, we tested the two compounds in
the same system and compared their effects on glycogen 
metabolism, on cyclic AMP and F-2.6-P 2 levels, on glu- 
cose production and on glycolysis. 
2. Materials and methods 
2.1. Materials 
The chemicals used are listed with their sources: en- 
zymes and coenzymes (S'~ma. St. Louis, USA and 
Boehringer-Mannheim GmbH, Germany). lactate (Serva. 
Heidelberg. Germany). alanine, glutamine, dihydroxyace- 
tone (Fluka. Bachs, CH), glucose, fructose, g!ycine (Merck, 
Basel, CH) pyruvate (Calbiochem. La Jolla, USA). 5- 
iodombercidin (Research Biochemicals, MA. USA), albu- 
mine bovine fraction V (Miles. Zurich. CH). UDP-D-[U- 
14C]glucose, cyclic AMP [3HI assay system (Amersham 
Rahn AG. Zurich, CH). Proglycosyn was a gift from Lilly 
Research Laboratories, Eli Lilly. Indianapolis, IN 46285. 
USA. All other chemicals were of analytical grade. 
2.2. Preparation and incubation of hepatocytes 
Hepatocytes from 18-24 h fasted male Wistar rats were 
prepared as described previously [9]. The viability of the 
cells was determined by trypan blue exclusion and was 
85-95%. (8-15)× 106 cells were incubated for I h under 
a O~/CO2 atmosphere (95/5%) at 37°C in Krebs bicar- 
bonate buffer containing 0.5% (w/v) albumin, defatted 
and dialyzed according to [I0]. Before addition of sub- 
strates, the cells were preincubated for 20 min in the 
presence or absence of Itu, Pro or both together. The 
inhibitors used in Fig. 5 were also preincubated with the 
cells. 
2.3. Analytical methods 
Fructose-2,6-bisphosphate wasdetermined using pyro- 
phosphate-dependent 6-phosphofructo-I-kinase from potato 
tubers as described in [11]. The enzyme was partially 
purified except hat the last purification step of the enzyme 
on DEAE-cellulose was omitted. The concentrations of 
fructose-6-phosphate us d in the assays was 20 mM for the 
determination of Vm~  and I mM in the assays with 
varying concentrations of F-2,6-P 2. 
Glucose [12], lactate [13] and pyruvate [14] were deter- 
mined spectrophotometrically in neutralized HCIOa-ex- 
tracts of the cell suspension. Glycogen was measured as 
glucose after acid hydrolysis [15]. Glycogen synthase a 
activity was measured at 25°C in the presence of 5 mM 
UDP-[U-laC]glncose. 1% glycogen, 4 mM EDTA. 20 mM 
KF, 50 mM Hepes (pH 7.8) and 10 mM Na,SO 4 [16]. 
Phosphorylase a activity ~as measured at 25°C in the 
presence of 50 mM glucose-l-phosphate. I% glycogen. 
150 mM NaF and 0.5 mM caffeine [17]. 
For the determination of cyclic AMP. the cells were 
freeze-thawed in 50 mM Tri~ buffer containing 4 mM 
EDTA (Titriplex lll) in order to prevent enzymatic degra- 
dation of cyclic AMP [18]. and then heated to 90°C for 
several minutes to coagulate protein. After centrifugation, 
cyclic AMP was determined in the supernatant using the 
cyclic AMP [3H] assay system from Amersham. 
2,4. Expression t~l results 
A value of 1.25 × 10 s cells per g liver wet weight was 
used for calculations [19,20]. The results are given as 
means + S.E. for the indicated numbers ol cell prepara- 
tions. Statistical differences were tested by Student's t-test 
[21]. When more than two groups were compared (Fig. 2). 
statistical differences were determined by one-way 
ANOVA followed by Fisher's protected least significant 
difference method [21 ]. 
3. Results 
3.1. Dose-response curces of glycogen, synthase a and 
phosphorylase a ill the presence of  Itu and Pro 
The optimal concentrations for stimulation of glycogen 
synthesis are reported to be 10-50/zM for Itu [I] and 100 
ixM for Pro [6]. Glycogen, synthase a and phosphorylase 
a concentrations were measured in cells preincubated with 
Itu and Pro and then incubated for 60 min with 10 mM 
glucose, 5 mM lactate-pyruvate (9:1) and an amino acid 
mixture containing 5 mM of each glutamine, alanine and 
glycine (Fig. I). Both effectors led to a marked stimulation 
of glycogen deposition. Maximal stimulation by Pro was 
achieved between 50 and 100 ArM (32 p, mol/g), whereas 
higher concentrations caused a lower stimulation. With ltu. 
the stimulation curve levelled out between I0 and 100/zM 
(30-33/zmol/g, Fig. la). Both effeetors timulated glyco- 
gen deposition to the same maximal extent but the potency 
of Pro was ten times less. In agreement with the proposed 
mechanisms of action of Itu (protein kinase inhibition [7]) 
and Pro (protein phosphatase timulation [5]), the stimula- 
tion curves of glycogen synthesis correlated well with the 
corresponding stimulation curves of synthase a activity 
(Fig. lb, r2=0.92 and 0.89) and the inhibition of 
phosphorylase a activity (Fig. Ic, r-" = 0.97 and 0.79). 
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3.2. Separate and combined effec'ts tm glycogen metabolism 
and (3"clio AMP leuuls 
The effects of I0 /zM Itu, I00 gM Pro or their 
combination were studied in the absence (Fig. 2a.c.e) and 
in the presence of amino acids (Fig. 2b.d,f). When amino 
acids were omitted, glycogen synthesis from gluco- 
neogenic substrates was significantly enhanced by ltu but 
clearly more so by Pro (Fig. 2a). A combined addition of 
Itu and Pro resulted in a very pronounced synergistic 
effect. The stimulation of glycogen production was signifi- 
cantly higher upon a combined addition compared to the 
calculated sums of glycogen after a separate addition of ha 
and Pro (36.4 versus 27.0, glucose and lactate-pyruvate 
and 44.7 versus 32.4. dihydroxyacetone: P < 0.05, hori- 
zontal lines). A similar pattern was observed for glycogen 
synthase a (Fig. 2c). Although the stimulation of Pro was 
not larger than that of ltu, their combination led again to a 
more than additive effect. The activity of phosphorylase a 
(Fig. 2e) was significantly inhibited by hu but stronger by 
Pro and further decreased by their combination. 
Addition of amino acids to the gluconeogenic substrates 
led to a significant increase of the values of glycogen (Fig. 
2b) and synthase a (Fig. 2d) in the absence and presence 
of either ltu or Pro. The effect of Pro, however, was equal 
to that of Itu and a combined addition no longer resulted in 
a synergistic stimulation. Further, the concentrations of 
glycogen and synthase a attained with Ira plus Pro in the 
presence and absence of amino acids ,,,,'ere the same, 
indicating that maximal concentrations of glycogen and 
synthase a within I h were achieved. The increase of 
phosphorylase a activity (Fig. 2f) induced by amino acids 
was clearly suppressed by both agents. 
Despite their similar effects there was a difference 
between Itu and Pro: in apparent contradiction of its 
glycogenic action, Itu significantly raised the levels of 
cyclic AMP from 0.25 +_ 0.01 to 0.34 +_ 0.03 nmol /g  (glu- 
cose and lactate-pyruvate, n = 4) and from 0.29 +_ 0.03 to 
0.44 +_ 0.03 nmol /g  (glucose. lactate-pyruvate and amino 
acids, n = 4), whereas Pro did not change them. After their 
combined addition, the cyclic AMP concentrations re- 
mained as high as observed with Itu alone. 
3.3. Dose-dependent inhibition o f  ./'ructo.~e-2.6-bi.wlu~s- 
pilate concentrations 
The dose-dependent effects of hu and Pro on the con- 
centrations of F-2.6-P, are shown in Fig. 3. In the presence 
of 10 mM glucose, lactate, pyruvate and amino acids, 
increasing concentrations of Itu and Pro resulted in a 
dramatic decrease of F-2.6-P, formation, hu was again 
more than 10 times more potent han Pro but at the highest 
effector concentrations used (50 and 500 /,tM, respec- 
tively), the decrease in the concentration F-2,6-P, was 
equally strong with Itu and Pro. Such a steep drop could 
indicate loss of cell viability. However. concomitant with 
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Fig. I. Con,.:entration-dependent eff c s of hu and Pro on glycogen 
s,,nthesis, ',ntha~,e a and phosphorytase ,~t. Hepatocytes ',,.ere incubated 
for i h v.ith 10 mM glucose. 5 mM lactate-pyruvate (9:i) and an amino 
acid mixture containing 5 mM of each glutamine, alanine and glycine: 
( © ). in the ~hsence ofeffector: preincubated with hu (O) or Pro ( • ) for 
20 rain. Values are the means+S.E~ for 4-8 different experiments. 
' " P < 0.01 '.er,.us control vaiues. ~ ~ P < O.OI for ;'alues in the pres- 
ence of ltu '.or,u, values in the presence ofcorresponding concentrations 
of Prt~ a~, determined byunpaired Student's t-test. 
the strong decrease in the concentrations of F-2.6-P_,. there 
was -fficient glycogen synthesis (Fig. la). Within the 
whole concentration range itu and with Pro up to 10(3 ,u,M 
8O 
there was a good correlation between I he  decreases of  
F-2.6-P, levels and the corresponding increases of glyco- 
gen ( r  "~ = 0.98 and 0.90. respectively). 
3.4. Efh'c'ts ~[ liu and Pro ~,ll glycolysis 
Since F-2.6-P, is an important positive effector of  the 
glycolytic enzyme 6-phosphofructo- I-kinase [21]. Itu and 
Pro were tested on glycolysis using 20 mM glucose as 
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substrate (Table 1). Glycolysis. measured by the formation 
of  lactate plus pyruvate, was inhibited with I0 /~M ltu by 
85% and this was paralelled by a 71% dect'ease of  F-2.6-P_, 
concentrations. A higher concemration of  Itu further de- 
creased glycolysis but not F-2,6-P,, formation, The inhibi- 
tion of  F-2.6-P 2 formation by 100 or 500 /zM Pro in the 
presence of glucose was only 30% or 50%, respectively 
and thus much weaker than the one observed with the 
substrate mixture shown in Fig. 3 (84% and 93% inhibi- 
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c 
1200 C C 
c . . . ._L_ 
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(e )  ( f  • 
1o A 8 10 B 
n 8 
~. s n B 
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Substrate Substrate 
Fig. 2. Effects of I0 /zM hu and 100 #M Pro in the presence or absence of amino acids. Hepatocytes were incubated for I h with 10 mM glucose and 5 
mM lactate-pyruvate (9:1) (G.I,.P. n = 7) or with I0 mM dihydroxyacetone (DHA, n = 5) either in the absence (a.c,e) or in the presence of an amino acid 
mixture containing 5 mM of each glutamine, alanine and glycine (b.d.f). Concentrations at the end of preincubation were 0.5 + 0.1 #mol/g (glycogen), 
173 + 18 mU/g (synthase) and 10.3 _+ 0.9 U/g (phosphorylase). The horizontal lines indicate the calculated sums of the concentrations of glycogen (a.b) 
and synthase a (c.d) after a separate addition of ltu and Pro. Statistical analysis: Columns with different index letters differed significantly (P < 0.05) 
within a substrate group as determined by least significant difference test; " P < 0.05 and " " P < 0.01 for values with amino acids versus corresponding 
values without amino acids as determined by paired Student's t-test. 
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Fig. 3. Dose-dependent fl~.cts of hu and Pro on F-2.b-P, formation. 
Substrates were 10 mM glucose, 5 mM lacuue-pyruvatc (9:1) and amino 
acids (5 mM of each glutamine, alanine and glycme). Incubation time 
was I h. (O). v, ithout efl~ctor: (Q), preincubated ~ith I0 .aM ha: t • ). 
preincubated with 100 /.tM Pro; 1•). preincubated ~ith hu plus Fro. 
Values are the means_+S.E, for 4--6 cell preparations. Unpaired t-test 
results: " P < 0.05 and " " P < 0.01 ~ersus control value~ wilhout efl~zc- 
tor. 
tion). As a result, glycolysis was inhibited only by 25-29ck. 
A combined addition of Itu and Pro led to an additional 
signif icant inhibition of  glycolysis and F-2,6-P, formation. 
The weak inhibition of  glycolysis by Pro, however, was 
observed only at 20 mM or higher glucose concentrations 
(Fig. 4). In the presence of  I0 mM glucose. Pro inhibited 
lactate plus pyruvate formation by 79% and ltu by 87%. 
3.5. Effect o f  Im and Pro on ghwose production 
Since Itu strongly decreased the concentration of  F-2,6- 
P,, we investigated whether the compound had an effect 
on gluconeogenesis (Table 2). Glucose production from 
lactate-pyruvate, dihydroxyacetone or fructose was stirnu- 
80 
so 
,so 
i ~o 
o - -  
10 20 30 40 
Glucose (raM) 
Fig. 4 Gluct~c concentration curve in the presence of Itu and Pro. 
Hepatoc~te, ~'.ere incubated for I h v,,ith different glucose concentrations. 
IO). control: I l l .  preincubated with 10 p.M hu: ( • I. preincubate.J 'xith 
ItXI ,u.M Prt~. Values are the means _+ S.E. for 5-7 L:ell preparations. 
Unpaired t-te,t results: " P < 0.05 and " " P < 0.OI versus control val- 
ues '.~ithout effector: ~ " P < 0.01 for values in the presence of hu versus 
~alue~ in the presence of corresponding concentrations of Pro. 
lated by I0 /xM Itu as reflected by the positive differences 
in glucose between control and hu-treated cells. 100 /.tM 
Pro. on the other hand. inhibited net glucose production 
from all gluconeogenic substrates tested. A comparison of 
the difference between the concentrations of  glucose in 
control and effector-treated cells to that of  glycogen re- 
vealed that ltu stimulated both glucose and glycogen pro- 
duction, whereas Pro stimulated only glycogen synthesis. 
although more efficiently than Itu. A good correlation 
between the decreases in glucose and increases in glyco- 
gen concentrations due to Pro ( r  -~= 0.93) confirms the 
observation of Guo et al. [6] that Pro diverts the gluco- 
neogenic flux into glycogen. Glucose production in the 
presence of  ltu plus Pro was even further decreased than 
with Pro alone, This further decrease in glucose production 
due to a combination of  ltu and Pro seemed to account for 
the additional increase in glycogen concentrations, ince 
Table I 
Effect of hu and Pro on glycolysis and the concentration f fructose-2,6-bisphospate 
Additions 
Glycolytic Effizctor Lactate plus Fructose-2.6-bis 
substrate (mM) (.u,M) pyruvate ( .u, mol/g) phosphate (nmol/g) 
Glucose (20) - 54.1 + 1.9 (8) 20.5 "t" 2.0 (5) 
Itu (10) 7.9 ~. !. 1 (8) " " 6.0 _+ 0.4 (5) " " 
ltu (50) 5.5 _ 0.7 (8I " " 6.0 + 0.4 (5) " " 
Pro t IOn1 40.5 _+ 1.9 (8) ' " 14.3 _+ 1.6 (5) " ' 
Pro (500) 38.3 _.+. 2.6 (8) " " 10.2 + 1.2 (5) " 
Itu + Pro(lO+ IO0) 3.4+0.4(8) " ": 5.2_+0.3(5) " . zz  
ltu + Pro 150 + 500) 2.3 _+ 0.3 (8) " " ~# 4.7 _+ 0.3 (5) " " ~# 
Cells were preincubated for 20 rain with the effectors before substrates were added. Incubation time was 60 rain. Endogenous lactate plus pyruvate 
formation ',,.,as 1.08+0.11 in the absence and 1.11 +0.16 and 1.12+O.43 #mol/g in the presence of Itu and Pro. respectively. Endogenous 
concentrations of fructose-2.6-biphosphate wer  0.46 ___ 0.08 in the absence and 0.19 _+ 0.03 and 0.12 + 0.05 nmol/g in the presence of Itu and Pro. 
respectivel~ The numbers of experiments are indicated in brackets. Unpaired t-test results: ' P < 0.05 and ' " P < 0.01 versus control values without 
effeetor; ° P<0.01 for values with 10.u.M ltu plus 100/zM versus values with 10.uMltu alone; ## P<O.OI for values with50 #M huplus500.u.M 
Pro versus values with 50 /zM hu alone. 
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and the inhibition was almost reversed in the presence of  
ADA (Fig. 5b). "[he stimulation of  glycogenesis by Itu. on 
ihe other hand. was not reduced, indicating that glycogen 
metabol ism may be less affected by a phosphorylatea ltu 
product than glycolysis. ADA did not influence the effect 
of Pro on glycogen synthesis. 
4. Discussion 
It was considered earlier that the effects of Itu and Pro 
on glycogen metabol ism may be based on a common 
mechanism of  action [I]. The two compounds were shown 
by different laboratories to stimulate glycogen synthesis in 
a manner that is different from the one of  amino acids 
[I .4-6].  Their  direct comparison in this study revealed that 
Pro. with a 10 times lower potency (Fig. 1), is the better 
stimulator of glycogenesis from glucose and gluconeognic 
substrates in the absence (Fig. 2. Table 2) but not in the 
presence of  amino acids (Fig. 2). Pro also leads to a 
stronger decrease of phosphorylase a concentration than 
Itu. provided that amino acids are absent (Fig. 2). When 
Itu and Pro are added together, their stimulatory effect on 
glycogen production and synthase a concentration is more 
than additive in the absence of  amino acids. This additive 
stimulation is concealed when amino acids are present 
presumably because of  an additional synergism of  amino 
acids and the combination of  itu plus Pro: the concentra- 
tions of  glycogen and synthase a attained with either Itu or 
Pro are further increased by the presence of  amino acids. 
But when itu and Pro are added together, glycogen and 
synthase a concentrations are the same in the absence and 
presence of amino acids, indicating that maximal  evels are 
attained. Cyclic AMP levels are increased by Itu and Itu 
plus Pro but not by Pro alone. Since glycogen production 
82 
the total amount of net gluct)sc and glycogen production 
by Itu plus Pro was the same as compared to ltu alone, 
Interestingly. Itu alone inhibited glucose produt, tion and 
stimulated glycogen synthesis to the same extent as Pro 
when the gluconeogenic snbstrates were supplemented with 
amino acids, resulting in a correlation coefficient equal to 
that of Pro (not shown). 
3.6. A phosphot3"lated metabolite is partly respot:sible fiJr 
the ~ffects o f  Itu 
It has been postulated that the effects of  Pro may be 
mediated by a metabolite [5] and Van Shaftingen and De 
Hoffmann proposed glucuronidated erivative(s) to be the 
active molecules of  Pro [8]. ltu, on the other hand, is not 
only an inhibitor but also a substrate for adenosine kinase 
[22] and we tested whether a phosphorylated product could 
be responsible for it,, effects on glycogen synthesis and 
glycolysis. With this aim in view. two inhibitors. Y-amino- 
5'deoxyadenosine (ADA),  another inhibitor of  adenosine 
kinase. [23,24] and 6-methylmercaptopurine riboside 
(MeMPR), were used. MeMPR.  an inhibitor of  purine 
[25.26] and glycogen synthesis [27]. was chosen for com- 
parison because it exerts its effects only after phosphoryla- 
tion by adenosine kinase [25,26]. Fig. 5a shows that 
MeMPR inhibited glycolysis from 20 mM glucose to the 
same extent as Itu. This inhibition could be cancelled by 
blocking the phosphorylation of  MeMPR with ADA. The 
inhibition of  lactate plus pyruvate formation by Itu was 
also reduced from 80% to 52-~ in the presence of  ADA.  
indicating that Itu acts partly via a phosphorylated product. 
The decrease of  glyco~ysis in the pesence of  Pro and ADA 
compared to Pro alone could be ascribed to the slight 
inihibiting effect of  ADA under control conditions. Glyco- 
gen production from glucose, lactate, pyruvate and amino 
acids was strongly depressed by the addition of  MeMPR 
Table 2 
Glucose and glycogen production different gluconegenic sub,;trates in the presence and absence of Itu and Pro 
Additions 
Glucoeneogenic (mM) Effector Glucose Gbcogen ...1 Gluco~'~ ...I Glycogen '. Glucose + glycogen 
(,uM) (p_mol/g) (/J.mol of glucose/g) (p.mol/g) ( gmol of glucose/g) I ,u, mol of glucose/g) 
Lactate-pyru;'ate (4.5-0.5) - 49.7 + 2.1 0.9 ± 0.1 
Itu (10) 58.4±2.5 2.9+0.4 
Pro (100) 40.9 + 1.0 12.2 ± 1.0 
Itu + Pro 33.3 5:2.2 26.7 ± 3.4 
Dihydroxyacetone (10) - 102.3 ± 6.3 3.5 ± 0.7 
Itu (10) 111.7±6.7 13.0+2.2 
Pro (1011) 87.8+3.8 21.05:1.1 
Itu + Pro 82.0 5:3.6 43.1 5:3.4 
Fructose 15) - 10/,.0 ± 3.2 5.8 ± 0.5 
Itu 1101 110.8±2.9 16.2+ 1.2 
Pro (100) 92.2 5:2.5 17,1 _+ 1.2 
hu + Pro 89.0 ± 2.2 38.3 ± 3.8 
+ 8.7 + 1.4 " " + 2.0 + 0.4 " " 10.7 + 1.6 " " 
-8 .8+ 1.6 " " +11.3+0.9 " " +2.5:t: 1.8 
-16.4:t:2.7 " .2c  +25.8__.4.3 ' -oo  +9.45:5.8 " " 
+9.4+2.2 " +9.5+ 1.9 *" +18.9+3.1 "" 
-14.5__.2.88 "" +17.5+1.0 "" +3.0±2.7 
-20.3 5:3.2 ' .';C +39.6-t-3.4 " .OC +19.35:3.6 " .00  
+10.8± 1.7 " " +10.4±2,4 " " +21.2±2.0 " " 
-7.8 + U.6 " " +11.35:1.0 " " +3.55:1.2 
-10.1±1.0 . .C  +32.5+3.6 .OC +22.4±3.8 -.CO 
Hepat(x:yles were preincubated for 20 min with the effectors before substrates were added. Incubation time ',,.'as 60 min. Glucose and glycogen 
concentrations after preincubation were 5.3.4- 0.5 ar.d 0.4 _4:. 0.1 /zmol/g, respecti,.,ely. Values are the uneans +S.E. of 7 experiments. Paired t-test result:.;: 
• P < 0,05 and " " P < 0.01 versus control values in the absence of ellector; o p < 0.05 and o ~ p < 0.01 for values with Itu + Pro versus values with 
Pro, 
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Fig. 5. Effects of inhibition of the phosph(~r.,,lation ~1 hu and 6-mcth'.l- 
mercaptopurine riboside by 5'-amino-5'-deox3aden~,sine. Ct,ntr~,l xzlluc~ 
and the effects of 20 #M 6-methyh'nercaptopurinc riho,ide (Me~',IPR). It) 
/,tM ltu and 100 p.M Pro on glycolysir, la) and g',lcL-gcn ,,.,.nthcsi~ (hiarc 
shown in the presence iv, hire bars) and absence (~re.~ har~) of the 
adenosine kinase inhibitor 5'-arnino-5'deox~adconsinc (ADA). The ~ub- 
strafes were 20 mM glucose (glycolysis) and 10 mM g[ucose. 4 .5 mM 
lactate. 0.5 mM pyruvate and 5 mM of each glutamine, alanine and 
glycine (glycogen synthesis). Incubation time ~a~ 1 h. The ~ alues are the 
means_+S.E, for 6-7 experiments. Statistical nal~,is: column~ with 
different index letters differed significantly (P < 0.()5) a,, determined b) 
least significant difference t st: " P < 0.05 and " " P < t).OI for xaluc,, 
with ADA versus corresponding valuc~, with~,ut ADA as determined b~ 
paired Student's t-test. 
is accelerated by a combination of ltu and Pro, the glyco- 
genie action of both effectors eems to be independent of 
changes in cyclic AMP concentrations. 
In the presence of I0 mM glucose, lactate-pyruvate and 
amino acids, ltu artd Pro decrease the concentration of 
F-2,6-P~ equally strong (Fig. 3). whereas with 20 mM 
glucose as substrate (Table I). Pro inhibits F-2.6-P 2 forma- 
tion to a much lesser extent than Itu. Since a drop in 
F-2,6-P:, a positive allosteric effector of 6-phosphofmc- 
tokinase !, results in an inhibition of glycolysis [28], the 
subsequent decrease of lactate plus pyruvate accumulation 
in the presence of Pro is correspondingly smaller than in 
the presence of Itu (Table I). When Itu and Pro are added 
together, inhibition of glycolysis and of F-2,6-P, l'ormatiot~ 
is significantly more pronounced than with Itu alone. The 
30% inhibition of glycolysis by 100 /zM Pro in the 
83 
presettce ttf 20 mM glucose is markedly weaker than the 
,.)ne ~b,,c~xcd x~ith 10 mM (79%. Fig. 3) or reported by 
Guo ctal.  [6] (83% inhibition of lactate formation). Obvi- 
ously. ,qtl~_t~c can o',ercome the inhibiting effect of Pro on 
glycol.~,is better than that of hu. 
The experiments with 5'-amino-5'-deoxyadenosine 
(ADA). un~thcr inhibitor of adenosine kinase [23.24] show 
that a phosphorylated product of hu is. at least in part. 
responsible for the inhibition of glyeolysis by ltu (Fig. 5a). 
The lack of sensitivity of glycogen metabolism to an 
inhibition of the phosphorylation of Itu (Fig. 5b) is in 
agreement with the results of Massilon et al. [7] which 
showed that hu directly inhibits protein kinases involved 
in the inactixation of phospborylase and activation of 
synthase. 
Unlike Pro ~hich inhibits net glucose synthesis by 
directing the gluconeogenic flux away from glucose and 
into glycogen (Table 2). [4-6], Itu stimulates net glucose 
production from gluconeogenic precursors and thus in- 
creases the o~erall rate of glucose (free glucose plus 
glycogen) lbrmation (Table 2). One may therefore con- 
elude that ltu affects, besides glycogen synthase, also the 
glucose-6-phosphate-glucokinase cycl , ltu has been re- 
ported to inhibit glucokinase of liver cytosol by 37% [7]. 
When llu is added together with Pro it not only supports 
thc stintuhlting effect of Pro on glycogenesis but also the 
inhibiting effect on net glucose production (Table 2). 
These rcsutts indicate that Pro redirects the enhanced 
production of glucose caused by ltu further into glycogen 
and therefore increases the glycogenic effect of hu. 
This study shows that hu and Pro have many similari- 
ties although they have no chemical analogy. They have 
almost identical effects on glycogen metabolism. However, 
since their combined effect on glycogen production is 
synergistic, it is unlikely that a common mechanism is 
involved. Further, Itu. but not Pro. raises t.he levels of 
cyclic AMP and stimulates net glucose production, whereas 
Pro apparently inhibits this process. On the other hand, 
they both reduce the concentration of F-2.6-P_, and inhibit 
glycolysis. The strong inhibition of F-2,6-P2 formation by 
ltu and Pro (Figs. 3 and 4) with a simultaneous stimulation 
of glycogenesis (Fig. In) seems to be inconsistent with the 
mechanisms of action proposed for the two compounds: 
Itu was identified as a general inhibitor of protein kinases. 
including cyclic AMP-dependent protein kinase [7] and 
Pro was found to stimulate protein phosphatase 2A [5]. 
Such properties hould result in an increase rather than the 
observed decrease in the concentration of F-2.6-P, since 
the only protein kinase known to catalyze phosphorylation 
of hepatic 6-phosphofructose-2-kinase/F-2.6-bisphos- 
phatase (PFK.,/F-2,6P_,ase) is cyclic AMP-dependent pro- 
tein kinase and dephosphorylation f the enzyme is cat- 
alyzed primarily by protein phosphatase 2A [28]. One may 
theretbre suggest that the two compounds regulate the 
concentration of F-2.6-P 2 by a different mechanism than 
that of glycogen. "[his could apply to Itu which 
R. FI i 'k ~,, r-lsler el aL /Bmch imica  et Biophvsica Acta I "~1 ' ~ 1996 77-84 
glycogen production directly whereas it inhibits glycolysis. 
at least in part, via a phosphorylated metabolite (Fig. 5). A 
further possibil ity would be that the inhibition of  F-2,6-P, 
formation by Itu and Pro occurs via direct inhibition of  
PFK , .  And again, in the case of Itu with its known 
inhibitory effect on kinases other than protein kinases 
(adenosine kinase [23.29.30]. glucokinase [7]). an inhibi- 
tion of  PFK ,  would be z: reasonable xplanation. Exactly 
how Itu and Pro or their raetabolites which, in apparent 
contradiction to their g lycogenic action, inhibit F-2,6-P 2 
formation remains to be established. An additional compar-  
ison of  Itu and Pro with purif ied enzymes,  e.g.. PFK : ,  
protein kinases and, in v iew of the effects of  Pro on lipid 
metabol ism [5]. acetyI-CoA carboxylase, would be worth- 
wile for further studies of  the interrelations involved in 
l iver cell functions. 
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